The Swiss National Research Programme NRP 63 recently featured Xeltis’ technology and the story of Dominika – the first patient treated with a Xeltis’ device – in an online article. NRP 63 is focusing on stem cells and regenerative medicine with the purpose of providing a boost to basic research in the field. Funded by the Swiss National Science Foundation, the National Research Programmes support research projects that contribute solutions to problems of national significance.

View full article